Abdol-Hossein Rezaeian

机构：Beth Israel Deaconess Medical Center, Harvard University, University of South Carolina · ORCID：0000-0002-8826-2157

发表论文 40 篇 · 总被引 990 次 · h-index 13

代表论文

• PROTAC technology for the treatment of Alzheimer’s disease: advances and perspectives (2022 · Acta Materia Medica · 被引 47)
• A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer (2024 · Cell chemical biology · 被引 29)
• Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer’s disease (2022 · Acta Materia Medica · 被引 27)
• Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase (2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 24)
• USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice (2023 · Science Translational Medicine · 被引 22)
• Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer (2023 · Neoplasia · 被引 16)